Flosequinan

CHEMBL1908307 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

239.3 g/mol

LogP

1.1

Phase

4

A vasodilator formerly investigated for the treatment of heart failure that works by relaxing blood vessels to reduce the workload on the heart. It was withdrawn from the market due to concerns about increased mortality with long-term use. Research into its mechanism contributed to the understanding of heart failure pharmacology.

Moleküler Ağırlık

239,2700 g/mol

LogP

1,10

TPSA

56,60 Å²

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

Cn1cc([S+](C)[O-])c(=O)c2ccc(F)cc21

InChI

InChI=1S/C11H10FNO2S/c1-13-6-10(16(2)15)11(14)8-4-3-7(12)5-9(8)13/h3-6H,1-2H3

Molecular Formula

C11H10FNO2S

HBD / HBA

- / 5

Döndürülebilir Bağlar

1

Ağır Atomlar

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A vasodilator formerly investigated for the treatment of heart failure that works by relaxing blood vessels to reduce the workload on the heart. It was withdrawn from the market due to concerns about increased mortality with long-term use. Research into its mechanism contributed to the understanding of heart failure pharmacology.

Yes, Flosequinan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1908307. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4474062. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Flosequinan PillFYI'da

Yapı

Hızlı Veriler

Formül: C11H10FNO2S

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.